[The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission].

Tímea Tőkés; Krisztián Somlai; Borbála Székely; Janina Kulka; Gyöngyvér Szentmártoni; László Torgyík; Hajna Galgóczy; Zsolt Lengyel; Tamás Györke; Magdolna Dank

doi:10.1556/OH.2012.29495

Publisher Website

[The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission].

Authors

Tőkés, Tímea
Somlai, Krisztián
Székely, Borbála
Kulka, Janina
Szentmártoni, Gyöngyvér
Torgyík, László
Galgóczy, Hajna
Lengyel, Zsolt
Györke, Tamás
Dank, Magdolna

Type

Published Article

Journal

Orvosi hetilap

Publication Date

Dec 09, 2012

Volume

153

Issue

49

Pages

1958–1964

Identifiers

DOI: 10.1556/OH.2012.29495

PMID: 23204302

Source

Medline

License

Unknown

Abstract

The metabolic changes were more sensitive in the measurement of the therapeutic response than morphological remission, and they correlated well with the pathological response, in not standardized clinical conditions even.

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. This record was last updated on 07/04/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM. The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/23204302

Report this publication

Statistics

Seen <100 times